IP Library Granted Patent US 8,648,213
Granted Patent B2
US 8,648,213 · App. 11/573,692 · Granted Feb 11, 2014

Prostamides for the treatment of glaucoma and related diseases

Inventors: David F. Woodward (Lake Forest, CA); Robert M. Burk (Laguna Beach, CA)
Assignee: Allergan, Inc.
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,648,213
App. No.
11/573,692
Granted
Feb 11, 2014
Kind
B2
Abstract

Disclosed herein are compositions comprising an amide related to a prostaglandin and a biogenic amine. Other aspects relate to certain chemical compounds, pharmaceutical compositions, and methods of treating glaucoma.

Claims (11)

1. A compound consisting of an amide related to a prostaglandin and a biogenic amine, wherein said compound is not naturally occurring, and wherein said compound has the structure:

or a salt, or ester, thereof,

wherein

the hatched wedge indicates an α configuration and the solid wedge indicates a β configuration;

A and B are both CHOH;

R 1 is phenyl, indolyl, or monohydroxy or dihydroxy derivatives of phenyl or indolyl;

R 2 is OH or H;

R 3 is n-butyl, n-pentyl, or n-hexyl; and

R 4 is hydrogen, methyl, ethyl, iso-propyl, or n-propyl.

2. The compound of claim 1 of the structure

3. A compound of the structure:

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 12, 2007
From: WOODWARD, DAVID W.; BURK, ROBERT M.
To: ALLERGAN, INC.
Reel/Frame 019414/0333 →
Continuity (2)
Provisional Application 60616780 · Oct 6, 2004
Related Publication 20080039507A1 · Feb 14, 2008